A phase II trial of reirradiation combined with pembrolizumab in patients with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck (HNSCC)

被引：0
|
作者：
Zandberg, Dan Paul
Bauman, Jessica R.
Mehra, Ranee
Molitoris, Jason K.
Jelinek, Mark
Wang, Hong
Clump, David Anthony, II
Skinner, Heath Devin
Ferris, Robert L.
Fenton, Moon Jung
Cullen, Kevin J.
Suntharalingam, Mohan
Bentzen, Soren
Giri, Anshu
Liu, Jeffrey C.
Galloway, Thomas James
机构：
[1] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
[3] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA
[4] Univ Maryland, Baltimore, MD USA
[5] UPMC Hillman Canc Ctr Biostat Facil, Pittsburgh, PA USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[8] UPMC Hillman Canc Ctr, Dept Radiat Oncol, Pittsburgh, PA USA
[9] Univ Maryland, Dept Med, Baltimore, MD USA
[10] Univ Maryland, Sch Med, Baltimore, MD USA
[11] Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6049
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II trial of pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): An interim analysis
    Karamouzis, M. V.
    Friedland, D.
    Johnson, R.
    Rajasenan, K.
    Branstetter, B.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial
    Feinstein, T. M.
    Raez, L. E.
    Rajasenan, K. K.
    Gibson, M. K.
    Savvides, P.
    Karamouzis, M. V.
    Garg, N.
    Johnson, R.
    Branstetter, B. F.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] PHASE-II TRIAL OF MITOGUAZONE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    PERRY, DJ
    CRAIN, SM
    WELTZ, MD
    WILSON, JP
    DAVIS, RK
    WOOLLEY, PV
    FORASTIERE, AA
    TAYLOR, HG
    WEISS, RB
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 91 - 92
  • [44] Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
    Shin, DM
    Glisson, BS
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Lee, JJ
    Lawhorn, K
    Gillenwater, AM
    Ang, KK
    Clayman, GL
    Callender, DL
    Hong, WK
    Lippman, SM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1325 - 1330
  • [45] Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck
    Glisson, BS
    Murphy, BA
    Frenette, G
    Khuri, FR
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1593 - 1599
  • [46] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [47] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Hypothyroidism After Primary Radiation Therapy in Squamous Cell Carcinoma of the Head and Neck (HNSCC)
    Roenjom, M.
    Brink, C.
    Hegedus, L.
    Overgaard, J.
    Johansen, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S61 - S61
  • [49] Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Tsao, A. S.
    Hong, W. K.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
  • [50] Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    Fury, Matthew G.
    Baxi, Shrujal
    Shen, Ronglai
    Kelly, Katherine W.
    Lipson, Brynna L.
    Carlson, Diane
    Stambuk, Hilda
    Haque, Sofia
    Pfister, David G.
    ANTICANCER RESEARCH, 2011, 31 (01) : 249 - 253
12345